Arsenic Trioxide in Treating Patients With Basal Cell Carcinoma
NCT01791894
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
5
Enrollment
OTHER
Sponsor class
Conditions
Basal Cell Carcinoma of the Skin
Recurrent Skin Cancer
Interventions
DRUG:
arsenic trioxide
Sponsor
Stanford University
Collaborators
[object Object]